<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001365731</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001158895</issuerCik>
      <issuerName>LEMAITRE VASCULAR INC</issuerName>
      <secFileNumber>001-33092</secFileNumber>
      <issuerAddress>
        <com:street1>63 SECOND AVENUE</com:street1>
        <com:city>BURLINGTON</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>01803</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>781-221-2266</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Roberts David B</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>The Charles Schwab Corporation</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>5025</noOfUnitsSold>
      <aggregateMarketValue>380305.56</aggregateMarketValue>
      <noOfUnitsOutstanding>22337216</noOfUnitsOutstanding>
      <approxSaleDate>05/06/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>11/07/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Compensation Grants</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>5025</amountOfSecuritiesAcquired>
      <paymentDate>11/07/2022</paymentDate>
      <natureOfPayment>Stock Compensation Grants</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>Title of account being sold out of: D. Roberts &amp; S. Roberts Ttee David B. Roberts 2003 Trust U/A Dtd 07/23/2003 Stock grants awarded from dates ranging from 11/07/2022 to 12/22/2022.</remarks>
    <noticeSignature>
      <noticeDate>05/06/2024</noticeDate>
      <signature>Roberts David B.</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2940}]
144
0001365731
XXXXXXXX
LIVE
0001158895
LEMAITRE VASCULAR INC
001-33092
63 SECOND AVENUE
BURLINGTON
MA
01803
781-221-2266
Roberts David B
Director
Common
The Charles Schwab Corporation
3000 Schwab Way
Westlake
TX
76262
5025
380305.56
22337216
05/06/2024
NASDAQ
Common
11/07/2022
Stock Compensation Grants
Issuer
N
5025
11/07/2022
Stock Compensation Grants
Y
Title of account being sold out of: D. Roberts & S. Roberts Ttee David B. Roberts 2003 Trust U/A Dtd 07/23/2003 Stock grants awarded from dates ranging from 11/07/2022 to 12/22/2022.
05/06/2024
Roberts David B.